Cantoni Therapeutics
Oss
About Cantoni Therapeutics
The mission of Cantoni Therapeutics is to find and create small molecule inhibitors of NNMT, a metabolic enzyme that is abundantly expressed in metabolic tissues such as muscle, adipose tissue, and the liver.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: cantonitx.nl
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cantoni-therapeutics-2420330 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.